Ontaril® (Cx401) is a product based on expanded stem cells obtained form adipose tissue (eASCs) for the treatment of perianal fistulas.
Cx501 is a product based on chimeric bilaminar skin for the treatment of epidermolysis bullosa.
Cellerix’s pipeline covers three main areas: gastroenterology, dermatology and immune system disorders.